跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOLALGIAL IBUPROFENO/CAFEINA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DOLALGIAL IBUPROFENO/CAFEINA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DOLALGIAL IBUPROFENO/CAFEINA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Opella Healthcare Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2020
Approval ID
764925deee21e5cf
Company
Opella Healthcare Spain S.L.
Type
Standard
Approval Details
Approval Id
764925deee21e5cf
Drug Cima Aemps Name
DOLALGIAL IBUPROFENO/CAFEINA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
85244
Holder Company Name
Opella Healthcare Spain S.L.
Marketing Company Name
Opella Healthcare Spain S.L.
Authorization Date
2020-07-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Opella Healthcare Spain S.L.
Active Ingredients
IBUPROFENO
400 mg
CAFEINA
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2020
Approval ID
764925deee21e5cf
Type
Standard
Back to CIMA-AEMPS Approvals